Literature DB >> 23325741

Rapid genotypic detection of rpoB and katG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR.

Anamika Gupta1, Pradyot Prakash, Surya K Singh, Shampa Anupurba.   

Abstract

BACKGROUND: There is a growing need to develop rapid laboratory research methods to counter the menace of drug resistant tuberculosis (MDR-TB) cases worldwide especially in developing countries. The present study was undertaken to investigate the type and frequency of rpoB and katG mutations in rifampicin (RIF) and isoniazid (INH) resistant strains respectively of Mycobacterium tuberculosis (MTB) circulating in Northern India and to explore the utility of multiplex-allele-specific (MAS)-PCR assay for detection of drug-resistant MTB isolates in low resource set up.
METHODS: Phenotypic and genotypic drug susceptibility testing (DST) was performed on 354 MTB isolates.
RESULTS: Mutation in rpoB gene was found most frequently at codons 531, 526 and 516 (59.83%, 45.29% and 22.22%, respectively). Further, combinations of 2-3 point mutations were also observed in 19.66% of RIF-resistant MTB strains. The frequency of mutations in katG gene was found at codon 315 among 82.95% of the INH-resistant MTB isolates. MAS-PCR detected rpoB and katG mutations in phenotypically resistant isolates with sensitivities of 93% and 83% respectively.
CONCLUSION: MAS-PCR assays can be used for rapid detection of drug-resistant TB strains in routine diagnostic practice, enabling early administration of appropriate treatment regimens to the affected patients.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23325741      PMCID: PMC6807317          DOI: 10.1002/jcla.21558

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  29 in total

1.  rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries.

Authors:  Lishi Qian; Chiyoji Abe; Tao-Ping Lin; Ming-Chih Yu; Sang-Nae Cho; Sumin Wang; James T Douglas
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Detection of mutation in isoniazid-resistant Mycobacterium tuberculosis isolates from tuberculosis patients in Belarus.

Authors:  S Z Bostanabad; L P Titov; A Bahrmand; S A Nojoumi
Journal:  Indian J Med Microbiol       Date:  2008 Apr-Jun       Impact factor: 0.985

3.  Rapid Detection of Mutation in RRDR of rpo B Gene for Rifampicin Resistance in MDR-Pulmonary Tuberculosis by DNA Sequencing.

Authors:  Surajeet Kumar Patra; Anju Jain; B L Sherwal; Ashwani Khanna
Journal:  Indian J Clin Biochem       Date:  2010-08-25

4.  Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia.

Authors:  Caroline Lavender; Maria Globan; Aina Sievers; Helen Billman-Jacobe; Janet Fyfe
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

Authors:  G Canetti; W Fox; A Khomenko; H T Mahler; N K Menon; D A Mitchison; N Rist; N A Smelev
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

6.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

7.  Detection of ethambutol-resistant Mycobacterium tuberculosis strains by multiplex allele-specific PCR assay targeting embB306 mutations.

Authors:  Igor Mokrousov; Olga Narvskaya; Elena Limeschenko; Tatiana Otten; Boris Vyshnevskiy
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

8.  Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain.

Authors:  M J Torres; A Criado; N Gónzalez; J C Palomares; J Aznar
Journal:  Int J Tuberc Lung Dis       Date:  2002-02       Impact factor: 2.373

9.  Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis.

Authors:  K Srivastava; R Das; P Jakhmola; P Gupta; D S Chauhan; V D Sharma; H B Singh; A S Sachan; V M Katoch
Journal:  Indian J Med Res       Date:  2004-08       Impact factor: 2.375

10.  Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears.

Authors:  Igor Mokrousov; Tatiana Otten; Boris Vyshnevskiy; Olga Narvskaya
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

View more
  11 in total

1.  Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.

Authors:  Divya Anthwal; Rakesh Kumar Gupta; Manpreet Bhalla; Shinjini Bhatnagar; Jaya Sivaswami Tyagi; Sagarika Haldar
Journal:  J Clin Microbiol       Date:  2017-03-22       Impact factor: 5.948

2.  Novel mutations detected from drug resistant Mycobacterium tuberculosis isolated from North East of Thailand.

Authors:  Ei Phoo Thwe; Wises Namwat; Porntip Pinlaor; Kulrattana Rueangsak; Arunnee Sangka
Journal:  World J Microbiol Biotechnol       Date:  2021-10-13       Impact factor: 3.312

3.  Rapid Detection of Genomic Mutations in gyrA and parC Genes of Escherichia coli by Multiplex Allele Specific Polymerase Chain Reaction.

Authors:  Sukanlayanee Onseedaeng; Panan Ratthawongjirakul
Journal:  J Clin Lab Anal       Date:  2016-04-13       Impact factor: 2.352

4.  Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay.

Authors:  Hatairat Kamphee; Angkana Chaiprasert; Therdsak Prammananan; Natpapas Wiriyachaiporn; Airin Kanchanatavee; Tararaj Dharakul
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

5.  Investigation of the rpoB Mutations Causing Rifampin Resistance by Rapid Screening in Mycobacterium Tuberculosis in North-East of Iran.

Authors:  Amir Tajbakhsh; Faezeh Ghasemi; Seyedeh Zohre Mirbagheri; Mastoureh Momen Heravi; Mehdi Rezaee; Zahra Meshkat
Journal:  Iran J Pathol       Date:  2018-09-25

6.  Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan.

Authors:  Sara Siddiqui; Meredith B Brooks; Amyn A Malik; Junaid Fuad; Ahsana Nazish; Safia Bano; Mercedes C Becerra; Hamidah Hussain
Journal:  PLoS One       Date:  2019-08-19       Impact factor: 3.240

7.  Development and evaluation of novel bio-safe filter paper-based kits for sputum microscopy and transport to directly detect Mycobacterium tuberculosis and associated drug resistance.

Authors:  Divya Anthwal; Surabhi Lavania; Rakesh Kumar Gupta; Ajoy Verma; Vithal Prasad Myneedu; Prem Prakash Sharma; Hitesh Verma; Viveksheel Malhotra; Ashawant Gupta; Nalini Kant Gupta; Rohit Sarin; Sagarika Haldar; Jaya Sivaswami Tyagi
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

8.  Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in M. tuberculosis Clinical Isolates from Western and Northern India.

Authors:  Vibhuti Rana; Nittu Singh; Chaitali Nikam; Priti Kambli; Pravin K Singh; Urmila Singh; Amita Jain; Camilla Rodrigues; Charu Sharma
Journal:  Infect Drug Resist       Date:  2022-04-08       Impact factor: 4.003

9.  Rapid Screening of MDR-TB in Cases of Extra Pulmonary Tuberculosis Using Geno Type MTBDRplus.

Authors:  Richa Kumari; Rajneesh Tripathi; Alok Prakash Pandey; Tuhina Banerjee; Pallavi Sinha; Shampa Anupurba
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

10.  Direct detection of Mycobacterium tuberculosis rifampin resistance in bio-safe stained sputum smears.

Authors:  Surabhi Lavania; Divya Anthwal; Manpreet Bhalla; Nagendra Singh; Sagarika Haldar; Jaya Sivaswami Tyagi
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.